"If this is verified by other studies, it could change guidelines for treatment of severe malaria in African children, and they are the biggest target group by far," says Chandy John, a specialist in paediatric infectious diseases at Indiana University in Indianapolis.
"The fact that it has now been identified specifically in children with severe malaria raises the threat level. The parasite that causes malaria, Plasmodium falciparum, is contracted through the bite of a mosquito."
"For severe malaria, which can involve symptoms such as convulsions, breathing problems and abnormal bleeding, treatment is more intensive. Physicians administer intravenous artesunate - a fast-acting version of artemisinin - for at least 24 hours."
Collection
[
|
...
]